144
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve risk stratification of this cancer.

          Related collections

          Author and article information

          Journal
          J Clin Endocrinol Metab
          The Journal of clinical endocrinology and metabolism
          The Endocrine Society
          0021-972X
          0021-972X
          Dec 2005
          : 90
          : 12
          Affiliations
          [1 ] Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA. mxing1@jhmi.edu
          Article
          jc.2005-0987
          10.1210/jc.2005-0987
          16174717
          4db5b41d-5f5d-40fb-8f34-cc124394f66e
          History

          Comments

          Comment on this article